Publications by authors named "Manuela Mayer"

Claim this Profile
P
Permeability of 16 Straight- and Branched-Chain Parabens Using the Caco-2 Assay.
Nicola J Hewitt, Manuela Mayer, Andreas Schepky, Corie Ellison

J Appl Toxicol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Human Stem Cell-Derived Brain-Liver Chip for Assessing Blood-Brain-Barrier Permeation of Pharmaceutical Drugs.
Leopold Koenig, Anja Patricia Ramme, Daniel Faust, Manuela Mayer, Tobias Flötke

Cells· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects.
Mohanraj Gopalswamy, Tobias Kroeger, David Bickel, Benedikt Frieg, Shahina Akter, Manuela Mayer

Sci Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and plasma protein binding of 16 straight- and branched-chain parabens in in vitro liver and skin models.
Cathy Lester, Nicola J Hewitt, Ursula Müller-Vieira, Manuela Mayer, Corie Ellison

Toxicol In Vitro· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Marc Lübberstedt, Ursula Müller-Vieira, Manuela Mayer, Klaus M Biemel, Fanny Knöspel

J Pharmacol Toxicol Methods· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements.
Simone Beckers, Fozia Noor, Ursula Müller-Vieira, Manuela Mayer, Alexander Strigun

Toxicol In Vitro· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis